期刊文献+

DICER基因多态性与食管癌淋巴结转移危险因素的关系

Association of Variant Allele of DICER and Decreased Risk of Esophageal Cancer Lymph Node Metastasis
下载PDF
导出
摘要 目的探讨中国汉族人群中DICER基因rs3742330多态性与食管癌淋巴结转移危险因素的关系。方法采用以医院为基础的病例-病例研究方法,采用基质辅助激光解析电离飞行时间质谱(MAL-DI-TOF MS)技术分析85例有淋巴结转移的食管癌和270例无淋巴结转移的食管癌DICER基因rs3742330基因多态性,计算各种基因型与食管癌淋巴结转移的发生风险及其95%可信区间。结果 DICER rs3742330 A>G多态三种基因型AA、AG、GG在食管癌淋巴结转移组的频率分别为31.76%、61.18%、7.06%,在无淋巴结转移组的频率分别为34.44%、48.15%、17.41%,与携带DICERrs3742330 AA基因型的个体相比较,DICER rs3742330 GG基因型显著减少食管癌淋巴结转移发生的危险。结论 DICER rs3742330 A>G基因多态性可能是食管癌淋巴结转移的保护性因素。 Objective To investigate the relationship between DICER polymorphism and the susceptibility to lymph node metastasis in esophageal cancer in Chinese Han population.Methods Genotypes were determined by matrix-assisted laser desorption /ionization time-of-flight mass spectrometry(MALDI-TOF MS) method in 85 lymph node metastasis positive patients and 270 lymph node metastasis negative patients.Results The DICER rs3742330 A〉G genotype frequencies were 31.76%(AA),61.18%(AG),7.06%(GG) in the lymph node positive group and 34.44%(AA),48.15%(AG),17.41%(GG) in the lymph node negative group,respectively.Logistic regression analyses revealed that the risk associated with DICER rs3742330 GG genotype was 0.36(95%CI=0.15~0.88) which was much lower than DICER rs3742330 AA+AG genotype.Conclusion DICER rs3742330 A〉G polymorphism may be a protective factor of lymph node metastasis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第7期822-825,共4页 Cancer Research on Prevention and Treatment
关键词 细胞周期检测点激酶2 食管癌 淋巴结转移 基质辅助激光解析电离飞行时间质谱 单核苷酸多态性 DICER Esophageal cancer Lymph node metastasis Matrix-assisted laser desorption/ioniza-tion time-of flight mass spectrometry Single nucleotide polymorphism
  • 相关文献

参考文献6

  • 1Yang M, Li Y, Padgett RW. MicroRNAs: Small regulators with a big impaet[J]. Cytokine Growth Factor Rev, 2005,16 (4-5) : 387-93.
  • 2Lin J, Horikawa Y, Tamboli P,et al. Genetic variations in mi croRNA-related genes are associated with survival and recur- rence in patients with renal cell carcinoma[J]. Carcinogenesis, 2010,31(10):1805-12.
  • 3Clague J, Lippman SM, Yang H, et al. Genetic variation in Mi- croRNA genes and risk of oral premalignant lesions[J]. Mol Carcinog, 2010,49 (2) : 183-9.
  • 4Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha,and out- comes in patients with ovarian cancer[J]. N Engl J Med,2008, 359(25) :2641-50.
  • 5Karube Y, Tanaka H, Osada H, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients [J]. Cancer Sci,2005,96(2) : 111-5.
  • 6Kumar MS, Lu J, Mercer KL, et al. Impaired microRNA pro- cessing enhances cellular transformation and tumorigenesis[J].Nat Genet,2007,39(5) :673-7.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部